1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 15-21, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 15-21, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 03/16/2026
Location: Baltimore, MD
Subject: Centers for Medicare and Medicaid Services Quality Conference; Panelist: HHS Leadership Panel
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of industry, government, academia, and other stakeholders

Event Date: 03/17/2026
Location: Washington, DC
Subject: Research and Development Leader Forum
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Event Date: 03/19/2026
Location: Washington, DC
Subject: Hever's 31st Annual Meeting; Speaker: Opening Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and other stakeholders

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

No Significant Event

Official Name: Sean R. Keveney, Chief Counsel

Event Date: 03/16/2026
Location: Washington, DC
Subject: Rare Disease Therapy for Spinocerebellar Ataxia (SCA)
FDA Participant/Group: N/A
Non FDA Participant/Group: Caitlin Koury (Checkmate Government Relations); Vlad Couric (Biohaven);

Event Date: 03/16/2026
Location: Washington, DC
Subject: Retatrutide
FDA Participant/Group: N/A
Non FDA Participant/Group: Anat Hakim, Dan Siegfried, Josh O'Harra (Lilly); Jim Johnson (Sidley and Austin, LLP);

Event Date: 03/16/2026
Location: Washington, DC
Subject: Approval Pathways
FDA Participant/Group: N/A
Non FDA Participant/Group: Patrick Johnson, Perry Stenberg (Sydnexis); Caitlin Koury (Checkmate Government Relations); Deborah L. Livornese (Hyman, Phelps and McNamara); Travis Mickle (Mickle Consulting);

Event Date: 03/17/2026
Location: Washington, DC
Subject: Ultra-Rare Disease Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Rebecca K. Wood (Sidley and Austin, LLP); Patrick Christmas (Regenxbio);

Event Date: 03/18/2026
Location: Washington, DC 
Subject: Direct to Consumer (DTC) Orthodontic Products
FDA Participant/Group: DAVID MEDNICK; 
Non FDA Participant/Group: Dale Anne Featheringham, Daniel Joseph, India Collier, Michael Durbin, Nathaniel Mick, Paul Lawrence, Steven Siegel (American Association of Orthodontist); Alexandra Campau (Cozen O’Connor Public Strategies);

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

Event Date: 03/17/2026
Location: Washington, DC
Subject: Human Foods Program Priorities 
FDA Participant/Group: LOWELL ZETA; 
Non FDA Participant/Group: Washington International Business Council representatives

Event Date: 03/18/2026
Location: Washington, DC
Subject: Ultra Processed Foods
FDA Participant/Group: N/A
Non FDA Participant/Group: Gaurav Parikh, Kristen Scott (Mondelez International); Max Becker (Smith Free Group);

Event Date: 03/19/2026
Location: Washington, DC
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: David Haines, Jim McGreevy, Sylvester Mosley (Coca Cola);

Event Date: 03/20/2026
Location: Virtual
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Steve Abrams (Univerisity of Texas at Austin, Dell Medical School); Carrie Swope, Jeff Hild (American Academy of Pediatrics);

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 03/19/2026
Location: Virtual
Subject: Coalition to Stop Flu Meeting 
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, regulatory, clinicians, and other stakeholders

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

Event Date: 03/17/2026
Location: Washington, DC
Subject: FDA Inspections Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Senator Rick Scott (FL-R)

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 03/16/2026
Location: Baltimore, MD
Subject: Centers for Medicare and Medicaid Services Quality Conference; Panelist: Technology-Enabled Care: ACCESS, TEMPO, and Outcome-Aligned Payments
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of industry, government, academia, and other stakeholders

Event Date: 03/18/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Medtronic representatives

Official Name: Tracy Beth Høeg M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

Event Date: 03/17/2026
Location: College Park, MD
Subject: AHI/CVM Triannual Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Animal Health Institute (AHI) representatives

Back to Top